NeuroSense Therapeutics Ltd.
NRSN
$1.14
-$0.0301-2.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 666.00K | 666.00K | 3.38M | 1.21M | 4.76M |
| Total Receivables | 847.00K | 847.00K | 164.00K | 376.00K | 309.00K |
| Inventory | -- | -- | 738.00K | -- | -- |
| Prepaid Expenses | -- | -- | 87.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 43.00K | 43.00K | 35.00K | 35.00K | 37.00K |
| Total Current Assets | 1.56M | 1.56M | 4.40M | 1.62M | 5.11M |
|
|
|||||
| Total Current Assets | 1.56M | 1.56M | 4.40M | 1.62M | 5.11M |
| Net Property, Plant & Equipment | 105.00K | 105.00K | 150.00K | 200.00K | 260.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.00K | 23.00K | 23.00K | 22.00K | 21.00K |
| Total Assets | 1.68M | 1.68M | 4.58M | 1.84M | 5.39M |
|
|
|||||
| Total Accounts Payable | 1.09M | 1.09M | 1.16M | 1.48M | 913.00K |
| Total Accrued Expenses | -- | -- | 759.00K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 73.00K | -- | -- |
| Total Finance Division Other Current Liabilities | 1.11M | 1.11M | -- | 2.03M | 1.90M |
| Total Other Current Liabilities | 1.11M | 1.11M | -- | 2.03M | 1.90M |
| Total Current Liabilities | 2.20M | 2.20M | 1.99M | 3.51M | 2.81M |
|
|
|||||
| Total Current Liabilities | 2.20M | 2.20M | 1.99M | 3.51M | 2.81M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 36.00K | 84.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 2.69M |
| Total Liabilities | 2.20M | 2.20M | 1.99M | 3.54M | 5.58M |
|
|
|||||
| Common Stock & APIC | 40.85M | 40.85M | 39.24M | 30.68M | 28.92M |
| Retained Earnings | -41.37M | -41.37M | -36.66M | -32.38M | -29.12M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -519.00K | -519.00K | 2.58M | -1.70M | -196.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -519.00K | -519.00K | 2.58M | -1.70M | -196.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -519.00K | -519.00K | 2.58M | -1.70M | -196.00K |
|
|
|||||